PEEP Setting in COVID19-related ARDS

Sponsor
Central Hospital, Nancy, France (Other)
Overall Status
Completed
CT.gov ID
NCT05115526
Collaborator
(none)
17
1
2
8.5

Study Details

Study Description

Brief Summary

The best way to titrate positive end-expiratory pressure (PEEP) in patients suffering from acute respiratory distress syndrome is still matter of debate. Electrical impedance tomography (EIT) in a non-invasive technique that could guide PEEP setting based on an optimized ventilation homogeneity.

Condition or Disease Intervention/Treatment Phase
  • Other: PEEP setting

Detailed Description

COVID-19 related ARDS patients admitted to the ICU in March 2021 requiring mechanical ventilation were enrolled. Patients were monitored by an esophageal catheter and a 32-electrode EIT device. Within 48 hours after the start of mechanical ventilation, different levels of PEEP were applied based upon PEEP/ Fraction of inspired oxygen tables, positive end-expiratory transpulmonary (PL)/ FiO2 table, and EIT. Respiratory mechanics variables were recorded.

Study Design

Study Type:
Observational
Actual Enrollment :
17 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Positive End-expiratory Pressure Setting in COVID-19 Related ARDS : Comparison Between Electrical Impedance Tomography, PEEP/ Fraction of Inspired Oxygen Tables, and Transpulmonary Pressure.
Actual Study Start Date :
Mar 1, 2021
Actual Primary Completion Date :
Mar 15, 2021
Actual Study Completion Date :
May 1, 2021

Outcome Measures

Primary Outcome Measures

  1. Value of PEEP [a single determination, within 24-48 hours after mechanical ventilation initiation]

    different PEEP values obtained through using different methods

Secondary Outcome Measures

  1. Respiratory mechanics [a single determination, within 24-48 hours after mechanical ventilation initiation]

    Respiratory mechanics (plateau pressure, driving pressure, compliance, mechanical power) following different PEEP settings

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • COVID19-related ARDS under invasive mechanical ventilation
Exclusion Criteria:
  • none

Contacts and Locations

Locations

Site City State Country Postal Code
1 Service de Réanimation Médicale, Hôpital Central Nancy France

Sponsors and Collaborators

  • Central Hospital, Nancy, France

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Central Hospital, Nancy, France
ClinicalTrials.gov Identifier:
NCT05115526
Other Study ID Numbers:
  • 2021PI117
First Posted:
Nov 10, 2021
Last Update Posted:
Nov 10, 2021
Last Verified:
Oct 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 10, 2021